LON:SL

Standard Life Aberdeen Share Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3.48 million shs
Average Volume9.39 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive SL News and Ratings via Email

Sign-up to receive the latest news and ratings for Standard Life Aberdeen and its competitors with MarketBeat's FREE daily newsletter.


Standard Life Aberdeen logo

About Standard Life Aberdeen

Standard Life Aberdeen plc, formerly Standard Life plc, is a United Kingdom-based global investment company. The Company operates through four segments, which include Aberdeen Standard Investments, Pensions and Savings, India and China, and Other. The Aberdeen Standard Investments segment provides a range of investment products for individuals and institutional customers through various investment vehicles. The Pensions and Savings provide a range of long-term savings and investment products to individual and corporate customers in the United Kingdom, Germany, Austria and Ireland. The businesses included in India and China offer a range of insurance and savings products and comprise its life insurance associate in India, its life insurance joint venture in China, and operations in Hong Kong. Its Other segment primarily includes the corporate center and related activities.

Headlines

Family’s joy after reunion with long-lost cat Forbes after decade
Family’s joy after reunion with long-lost cat Forbes after decade
September 20, 2021 |  msn.com
Aberdeen Asia-Pacific Income Investment Company Limited Update on Re-Domiciliation and Annual Redemption Feature Announced
Aberdeen Asia-Pacific Income Investment Company Limited Update on Re-Domiciliation and Annual Redemption Feature Announced
August 25, 2021 |  finanznachrichten.de
Industrial Mezzanines Market: Partnership between Major - GlobeNewswire
Industrial Mezzanines Market: Partnership between Major - GlobeNewswire
August 23, 2021 |  globenewswire.com
Pan American Energy, S.L., Argentine Branch -- Moodys announces completion of a periodic review of ratings of Pan American Energy, S.L. - Markets Insider
Pan American Energy, S.L., Argentine Branch -- Moody's announces completion of a periodic review of ratings of Pan American Energy, S.L. - Markets Insider
August 20, 2021 |  markets.businessinsider.com
So Much Amazing Character. Leica 16-35mm F3.5-4.5 SL Review - Yahoo Tech
So Much Amazing Character. Leica 16-35mm F3.5-4.5 SL Review - Yahoo Tech
August 19, 2021 |  finance.yahoo.com
Shattuck Labs Reports Second Quarter 2021 Financial Results - GlobeNewswire
Shattuck Labs Reports Second Quarter 2021 Financial Results - GlobeNewswire
August 11, 2021 |  globenewswire.com
Global Biometrics Market Size to Reach USD 99.63 Billion in 2027 | Increasing Penetration of Smartphones Around the World and Increasing Integration of Biometric Systems with Iot Devices are Some Key Factors Driving Industry Demand, says Emergen Res - Yahoo Finance
Global Biometrics Market Size to Reach USD 99.63 Billion in 2027 | Increasing Penetration of Smartphones Around the World and Increasing Integration of Biometric Systems with Iot Devices are Some Key Factors Driving Industry Demand, says Emergen Res - Yahoo Finance
August 9, 2021 |  finance.yahoo.com
TG Therapeutics: Time to Bottom Fish? - Nasdaq
TG Therapeutics: Time to Bottom Fish? - Nasdaq
August 4, 2021 |  nasdaq.com
TG Therapeutics Provides Business Update and Reports Second - GlobeNewswire
TG Therapeutics Provides Business Update and Reports Second - GlobeNewswire
August 2, 2021 |  globenewswire.com
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia - Business Wire
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia - Business Wire
July 29, 2021 |  businesswire.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Standard Life Aberdeen (LON:SL) Frequently Asked Questions

What stocks does MarketBeat like better than Standard Life Aberdeen?

Wall Street analysts have given Standard Life Aberdeen a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Standard Life Aberdeen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Standard Life Aberdeen's key executives?

Standard Life Aberdeen's management team includes the following people:
  • Martin James Gilbert M.D., Co-Chief Executive Officer, Executive Director (Age 63)
  • Keith Skeoch, Co-Chief Executive Officer, Executive Director (Age 61)
  • Bill Rattray, Chief Financial Officer, Executive Director (Age 59)
  • Rod Paris, Chief Investment Officer, Executive Director (Age 58)
  • Kenneth A. Gilmour, Company Secretary
  • Gerald E. Grimstone, Non-Executive Chairman of the Board (Age 68)
  • Simon Troughton, Non-Executive Independent Deputy Chairman of the Board (Age 64)
  • Julie Chakraverty, Non-Executive Independent Director (Age 46)
  • John Devine, Non-Executive Independent Director (Age 59)
  • Gerhard Fusenig, Non-Executive Independent Director (Age 54)

What other stocks do shareholders of Standard Life Aberdeen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Standard Life Aberdeen investors own include Standard Life Aberdeen (SLA), Lloyds Banking Group (LLOY), Barclays (BARC), Taylor Wimpey (TW), Aviva (AV), Standard Life Aberdeen (SLFPF), Tesco (TSCO), Experian (EXPN), GlaxoSmithKline (GSK) and HSBC (HSBA).

What is Standard Life Aberdeen's stock symbol?

Standard Life Aberdeen trades on the London Stock Exchange (LON) under the ticker symbol "SL."

How do I buy shares of Standard Life Aberdeen?

Shares of SL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Standard Life Aberdeen's official website?

The official website for Standard Life Aberdeen is www.standardlifeaberdeen.com.

Where are Standard Life Aberdeen's headquarters?

Standard Life Aberdeen is headquartered at Standard Life House, 30 Lothian Road, EDINBURGH, EH1 2DH, United Kingdom.

How can I contact Standard Life Aberdeen?

Standard Life Aberdeen's mailing address is Standard Life House, 30 Lothian Road, EDINBURGH, EH1 2DH, United Kingdom. The company can be reached via phone at +44-131-2252552.


This page was last updated on 9/22/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.